Hernia repair devices provide permanent reinforcement to the mended hernia and support damaged tissue surrounding it as it heals.
The Growing Adoption of Hernia Mesh Products for Hernia Repair Drives the Demand in Hernia Repair Devices Market
Hernia mesh is a biomaterials-based implant class that has been successfully utilized in clinical applications. These devices are typically categorized into two main groups: synthetic mesh and biologic/biological mesh. The use of hernia mesh products for surgical repair or reconstruction of anatomical defects has been commonly adopted. According to the FDA, hernia mesh is used in about 90% of hernia repair surgeries. For instance,
? In March 2023, TELA Bio, Inc announced that the Company’s OviTex PRS Long-Term Resorbable product has received the U.S. Food and Drug Administration 510(k) clearance for the Company’s OviTex PRS Long-Term Resorbable product
Robotic Surgeries Open Growth Opportunities in the Hernia Repair Devices Market
Hernia repair is one of the most common surgical treatments performed worldwide. The number of hernia repair surgeries has been increasing and is expected to continue. This growth can be accredited to various risk factors, including obesity and previous abdominal surgeries. Robotic surgery has risen as a newer technique for treating smaller hernias or weak areas and reconstructing the abdominal wall. Robotic surgery also allows the surgeon to easily use stitches to sew tissue and meshes inside the abdomen. Advantages of robotic surgery include three-dimensional images of the inside of the abdomen, smaller scars, and less pain.
The Rising Prevalence of Inguinal Hernia Drives the Hernia Repair Devices Market
Inguinal hernias make up approximately 75% of all abdominal wall hernias, with men facing a lifetime risk ranging from 27% to 43%, while women have a lower risk of 3% to 6%. The risk factors for inguinal hernia (IH) include family history, previous contra-lateral hernia, male gender, age, abnormal collagen metabolism, prostatectomy, and low body mass index. The increased incidence of inguinal cases among an older population is projected to stimulate demand for hernia repair equipment.
Key Challenges: Hernia Repair Devices Market
The high cost of the hernia repair procedures and the risk & complications associated with hernia repairs such as pain, infection, hernia recurrence, adhesion, and bowel obstruction are likely to impede the growth of the hernia repair devices market in the coming years.
North America Expected to Continue to Hold a Major Share in the Hernia Repair Devices Market
From a geographical outlook, North America dominates the market for hernia repair devices, holding a significant share of the market. This can be Primarily attributed to the growing prevalence of hernia disorders, higher adoption of new and advanced hernia repair devices, and advancements in hernia repair surgery technology, in the region.
Competitive Landscape
A few of the key players operating in the market include Medtronic, B Braun, Cook Medical, Baxter, and TELA Bio, among others.
Organic and Inorganic Growth Strategies Adopted by Players to Cement Their Foothold in the Hernia Repair Devices Market
Companies operating in this market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to gain market share. For instance,
? In February 2023, TELA Bio, Inc announced the introduction of two additional configurations of its OviTex LPR device. The new configurations are 15 x 20 cm and 15 x 25 cm ellipses designed for ventral and incisional hernias
? In December 2022, Deep Blue Medical Advances announced that they have received an additional 510(k) clearance from the US FDA for its T-Line Hernia Mesh for the subway technique in open hernia surgery
Get Detailed Insights on the Hernia Repair Devices Market @ https://meditechinsights.com/hernia-repair-devices-market/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
